Literature DB >> 23209300

Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone.

Shalini Thakran1, Pragya Sharma, Ramy R Attia, Roderick T Hori, Xiong Deng, Marshall B Elam, Edwards A Park.   

Abstract

Sirtuin 1 (SIRT1) is a nuclear deacetylase that modulates lipid metabolism and enhances mitochondrial activity. SIRT1 targets multiple transcription factors and coactivators. Thyroid hormone (T(3)) stimulates the expression of hepatic genes involved in mitochondrial fatty acid oxidation and gluconeogenesis. We reported that T(3) induces genes for carnitine palmitoyltransferase (cpt1a), pyruvate dehydrogenase kinase 4 (pdk4), and phosphoenolpyruvate carboxykinase (pepck). SIRT1 increases the expression of these genes via the activation of several factors, including peroxisome proliferator-activated receptor α, estrogen-related receptor α, and peroxisome proliferator-activated receptor γ coactivator (PGC-1α). Previously, we reported that PGC-1α participates in the T(3) induction of cpt1a and pdk4 in the liver. Given the overlapping targets of T(3) and SIRT1, we investigated whether SIRT1 participated in the T(3) regulation of these genes. Resveratrol is a small phenolic compound whose actions include the activation of SIRT1. Addition of resveratrol increased the T(3) induction of the pdk4 and cpt1a genes in hepatocytes. Furthermore, expression of SIRT1 in hepatocytes mimicked resveratrol in the regulation of gene expression by T(3). The deacetylase activity of SIRT1 was required and PGC-1α was deacetylated following addition of T(3). We found that SIRT1 interacted directly with T(3) receptor (TRβ). Knockdown of SIRT1 decreased the T(3) induction of cpt1a and pdk4 and reduced the T(3) inhibition of sterol response element binding protein (srebp-1c) both in isolated hepatocytes and in rat liver. Our results indicate that SIRT1 contributes to the T(3) regulation of hepatic genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23209300      PMCID: PMC3543030          DOI: 10.1074/jbc.M112.437970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways.

Authors:  Joseph T Rodgers; Carles Lerin; Zachary Gerhart-Hines; Pere Puigserver
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

2.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.

Authors:  Jérôme N Feige; Marie Lagouge; Carles Canto; Axelle Strehle; Sander M Houten; Jill C Milne; Philip D Lambert; Chikage Mataki; Peter J Elliott; Johan Auwerx
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

Review 3.  The role of sirtuins in the control of metabolic homeostasis.

Authors:  Jiujiu Yu; Johan Auwerx
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

4.  Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray.

Authors:  X Feng; Y Jiang; P Meltzer; P M Yen
Journal:  Mol Endocrinol       Date:  2000-07

5.  Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation.

Authors:  Nicole Engel; Ulrich Mahlknecht
Journal:  Int J Mol Med       Date:  2008-02       Impact factor: 4.101

6.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

Authors:  Aparna Purushotham; Thaddeus T Schug; Qing Xu; Sailesh Surapureddi; Xiumei Guo; Xiaoling Li
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

7.  SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription.

Authors:  Ramon Amat; Gemma Solanes; Marta Giralt; Francesc Villarroya
Journal:  J Biol Chem       Date:  2007-09-20       Impact factor: 5.157

8.  Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1.

Authors:  Joseph T Rodgers; Pere Puigserver
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

9.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.

Authors:  Jill C Milne; Philip D Lambert; Simon Schenk; David P Carney; Jesse J Smith; David J Gagne; Lei Jin; Olivier Boss; Robert B Perni; Chi B Vu; Jean E Bemis; Roger Xie; Jeremy S Disch; Pui Yee Ng; Joseph J Nunes; Amy V Lynch; Hongying Yang; Heidi Galonek; Kristine Israelian; Wendy Choy; Andre Iffland; Siva Lavu; Oliver Medvedik; David A Sinclair; Jerrold M Olefsky; Michael R Jirousek; Peter J Elliott; Christoph H Westphal
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

Review 10.  Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.

Authors:  John D Baxter; Paul Webb
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

View more
  29 in total

1.  Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.

Authors:  Brijesh K Singh; Rohit A Sinha; Jin Zhou; Madhulika Tripathi; Kenji Ohba; Mu-En Wang; Inna Astapova; Sujoy Ghosh; Anthony N Hollenberg; Karine Gauthier; Paul M Yen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

2.  FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.

Authors:  Brijesh Kumar Singh; Rohit Anthony Sinha; Jin Zhou; Sherwin Ying Xie; Seo-Hee You; Karine Gauthier; Paul Michael Yen
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

3.  SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D3 signaling via vitamin D receptor deacetylation.

Authors:  Marya S Sabir; Zainab Khan; Chengcheng Hu; Michael A Galligan; Christopher M Dussik; Sanchita Mallick; Angelika Dampf Stone; Shane F Batie; Elizabeth T Jacobs; G Kerr Whitfield; Mark R Haussler; Michael C Heck; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2017-06-19       Impact factor: 4.292

4.  Genetic Control of Fatty Acid β-Oxidation in Chronic Obstructive Pulmonary Disease.

Authors:  Zhiqiang Jiang; Nelson H Knudsen; Gang Wang; Weiliang Qiu; Zun Zar Chi Naing; Yan Bai; Xingbin Ai; Chih-Hao Lee; Xiaobo Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

Review 5.  Thyroid hormone analogues and derivatives: Actions in fatty liver.

Authors:  Maria Coppola; Daniela Glinni; Maria Moreno; Federica Cioffi; Elena Silvestri; Fernando Goglia
Journal:  World J Hepatol       Date:  2014-03-27

6.  Thyroid hormone status regulates the expression of secretory phospholipases.

Authors:  Pragya Sharma; Tania Levesque; Eric Boilard; Edwards A Park
Journal:  Biochem Biophys Res Commun       Date:  2014-01-16       Impact factor: 3.575

7.  Exogenous thyroxine improves glucose intolerance in insulin-resistant rats.

Authors:  Guillermo Vazquez-Anaya; Bridget Martinez; José G Soñanez-Organis; Daisuke Nakano; Akira Nishiyama; Rudy M Ortiz
Journal:  J Endocrinol       Date:  2016-12-15       Impact factor: 4.286

8.  Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis.

Authors:  Rita S Strakovsky; Huan Wang; Nicki J Engeseth; Jodi A Flaws; William G Helferich; Yuan-Xiang Pan; Stéphane Lezmi
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-05       Impact factor: 4.219

9.  Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling.

Authors:  Rohit A Sinha; Brijesh K Singh; Jin Zhou; Yajun Wu; Benjamin L Farah; Kenji Ohba; Ronny Lesmana; Jessica Gooding; Boon-Huat Bay; Paul M Yen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 10.  Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.

Authors:  Rohit A Sinha; Eveline Bruinstroop; Brijesh K Singh; Paul M Yen
Journal:  Thyroid       Date:  2019-09       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.